Hemochromatosis echocardiography or ultrasound: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
==Echocardiogram==
==Echocardiogram==
Based on the history, the [[physician|doctor]] might consider specific tests to monitor organ dysfunction, such as an [[echocardiogram]] for [[heart failure]].<ref name="pmid2959141">{{cite journal| author=Olson LJ, Baldus WP, Tajik AJ| title=Echocardiographic features of idiopathic hemochromatosis. | journal=Am J Cardiol | year= 1987 | volume= 60 | issue= 10 | pages= 885-9 | pmid=2959141 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2959141  }}</ref>
Based on the history, the [[physician|doctor]] might consider specific tests to monitor organ dysfunction, such as an [[echocardiogram]] for [[heart failure]].<ref name="pmid2959141">{{cite journal| author=Olson LJ, Baldus WP, Tajik AJ| title=Echocardiographic features of idiopathic hemochromatosis. | journal=Am J Cardiol | year= 1987 | volume= 60 | issue= 10 | pages= 885-9 | pmid=2959141 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2959141  }}</ref>
* It is used to dignose the involment of heart and stage the progress of cardiac function.


It is used to dignose the involment of heart and stage the progress of cardiac function.
* Echocardiography plays a role in the diagnosis and follow up during treatment.
* Findings are non-specific, with a restrictive or dilated cardiomyopathy profile.
* Mild left ventricular dilatation, normal or mildly increased wall thickness, biatrial enlargement. Right ventricular involvement with normal size and increased wall thickness.
* Left ventricular diastolic function – precedes systolic dysfunction. The degree of impairment correlates with the severity of iron overload, with a restrictive filling pattern in advanced stages Palka et al<ref name="pmid18609062">{{cite journal| author=Davidsen ES, Omvik P, Hervig T, Gerdts E| title=Left ventricular diastolic function in patients with treated haemochromatosis. | journal=Scand Cardiovasc J | year= 2009 | volume= 43 | issue= 1 | pages= 32-8 | pmid=18609062 | doi=10.1080/14017430802203811 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18609062  }}</ref>
* '''Iron overload cardiomyopathy''':
* '''Iron overload cardiomyopathy''':
** Hereditary (primary) hemochromatosis, an autosomal recessive disorder characterized by gene mutations involving iron metabolism, leading to increase iron uptake in the gastrointestinal tract.
** Hereditary (primary) hemochromatosis, an autosomal recessive disorder characterized by gene mutations involving iron metabolism, leading to increase iron uptake in the gastrointestinal tract.

Revision as of 23:29, 3 December 2017

Hemochromatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemochromatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemochromatosis echocardiography or ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemochromatosis echocardiography or ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemochromatosis echocardiography or ultrasound

CDC on Hemochromatosis echocardiography or ultrasound

Hemochromatosis echocardiography or ultrasound in the news

Blogs on Hemochromatosis echocardiography or ultrasound

Directions to Hospitals Treating Hemochromatosis

Risk calculators and risk factors for Hemochromatosis echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Based on the history, the doctor might consider specific tests to monitor organ dysfunction, such as an echocardiogram for heart failure.

Echocardiogram

Based on the history, the doctor might consider specific tests to monitor organ dysfunction, such as an echocardiogram for heart failure.[1]

  • It is used to dignose the involment of heart and stage the progress of cardiac function.
  • Echocardiography plays a role in the diagnosis and follow up during treatment.
  • Findings are non-specific, with a restrictive or dilated cardiomyopathy profile.
  • Mild left ventricular dilatation, normal or mildly increased wall thickness, biatrial enlargement. Right ventricular involvement with normal size and increased wall thickness.
  • Left ventricular diastolic function – precedes systolic dysfunction. The degree of impairment correlates with the severity of iron overload, with a restrictive filling pattern in advanced stages Palka et al[2]
  • Iron overload cardiomyopathy:
    • Hereditary (primary) hemochromatosis, an autosomal recessive disorder characterized by gene mutations involving iron metabolism, leading to increase iron uptake in the gastrointestinal tract.
    • Transfusional hemochromatosis secondary to chronic blood transfusions in patients with ineffective erythropoiesis (increased catabolism) as found in thalassemia or sickle cell anemia.

Ultrasound

References

  1. Olson LJ, Baldus WP, Tajik AJ (1987). "Echocardiographic features of idiopathic hemochromatosis". Am J Cardiol. 60 (10): 885–9. PMID 2959141.
  2. Davidsen ES, Omvik P, Hervig T, Gerdts E (2009). "Left ventricular diastolic function in patients with treated haemochromatosis". Scand Cardiovasc J. 43 (1): 32–8. doi:10.1080/14017430802203811. PMID 18609062.


Template:WH Template:WS